Valuation: Stem Cells Spin S.A.

Market Cap	19.84M 5.03M 4.51M 4.14M 3.76M 7.02M 478M 7.15M 49.43M 251M 18.88M 18.48M 792M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	19.93M 5.05M 4.53M 4.16M 3.77M 7.05M 480M 7.18M 49.64M 252M 18.96M 18.56M 796M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	57.28%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news: Stem Cells Spin S.A.

08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-16	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-14	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
15/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	01/01/2017

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	28/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	15/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	+2.13%	+9.09%	+21.21%	+33.33%	5.03M
WUXI APPTEC CO., LTD.	-0.62%	-1.87%	+42.87%	+64.15%	63.77B
ARGENX SE	+0.35%	+3.20%	+14.40%	+81.76%	56.37B
LONZA GROUP AG	+0.53%	+1.96%	+16.24%	+103.35%	54.62B
IQVIA HOLDINGS INC.	-2.81%	-4.31%	+23.50%	+47.83%	44.06B
BEONE MEDICINES AG	-0.33%	-1.93%	+19.28%	+98.80%	42.11B
REVOLUTION MEDICINES, INC.	+0.55%	+2.31%	+225.14%	+866.21%	41B
GENMAB A/S	+3.27%	+47.96%	+112.84%	+96.58%	34.92B
CELLTRION, INC.	+1.22%	-1.44%	+14.57%	+46.95%	32.82B
INSMED INCORPORATED	+0.89%	+20.55%	-40.62%	+349.24%	24.7B
Average	+0.52%	+7.69%	+44.94%	+178.82%	39.43B
Weighted average by Cap.	+0.18%	+5.44%	+47.99%	+176.67%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-16 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
28/10/26	PLN 0.4800	+2.13%	670
27/10/26	PLN 0.4700	-.--%	20
26/10/26	PLN 0.4700	+6.82%	10

End-of-day quote Warsaw S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. 28/10/2026			5-day change	1st Jan Change
0.4800 ^PLN	+2.13%		+9.09%	+18.23%

1 day	+2.13%
1 week	+9.09%
1 month	-4.00%
3 months	-2.04%
6 months	+20.00%
Current year	+18.23%

1 week	0.47	0.48
1 month	0.44	0.49
Current year	0.33	0.54
1 year	0.28	0.54
3 years	0.14	0.82
5 years	0.14	1.12
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 13.76K 12.33K 11.34K 10.27K 19.2K 1.31M 19.56K 135K 687K 51.65K 50.56K 2.17M	65.74K 16.67K 14.93K 13.73K 12.44K 23.26K 1.58M 23.69K 164K 833K 62.56K 61.23K 2.63M
Net income	-520K -132K -118K -109K -98.47K -184K -12.53M -188K -1.3M -6.59M -495K -485K -20.78M	-526K -133K -119K -110K -99.49K -186K -12.66M -189K -1.31M -6.66M -500K -490K -20.99M
Net Debt	69.28K 17.57K 15.73K 14.47K 13.11K 24.51K 1.67M 24.97K 173K 877K 65.93K 64.53K 2.77M	84.58K 21.45K 19.21K 17.67K 16.01K 29.93K 2.04M 30.49K 211K 1.07M 80.49K 78.78K 3.38M

Stem Cells Spin S.A. Stock

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news: Stem Cells Spin S.A.

Quotes and Performance

Price Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes